Tin Protoporphyrin Provides Protection Following Cerebral Hypoxia-ischemia: Involvement of Alternative Pathways
Overview
Authors
Affiliations
The contribution of heme oxygenase (HO)-linked pathways to neurodegeneration following cerebral hypoxia-ischemia (HI) remains unclear. We investigated whether HO modulators affected HI-induced brain damage and explored potential mechanisms involved. HI was induced in 26-day-old male Wistar rats by left common carotid artery ligation, followed by exposure to a humidified atmosphere of 8% oxygen for 1 hr. Tin protoporphyrin (SnPP; an HO inhibitor), ferriprotoporphyrin (FePP; an HO inducer), or saline was administered intraperitoneally once daily from 1 day prior to HI until sacrifice at 3 days post-HI. SnPP reduced (P < 0.05) infarct volume compared with saline-treated animals, but FePP had no effect on brain injury. SnPP did not significantly inhibit HO activity at 3 days post-HI, but SnPP increased (P < 0.001) total nitric oxide synthase (NOS) activity compared with HI + saline. Both inducible NOS and cyclooxygenase activities were attenuated (P < 0.05) by SnPP, whereas mitochondrial complex I and V activities were augmented (P < 0.05) by SnPP. SnPP had no effect on NMDA receptor currents. Overall, like other HO inhibitors, SnPP produced many nonselective effects, such as attenuation of inflammatory enzymes and increased mitochondrial respiratory function, which were associated with a protective response 3 days post-HI.
Lamy A, Chertow G, Jessen M, Collar A, Brown C, Mack C EClinicalMedicine. 2024; 68:102364.
PMID: 38586479 PMC: 10994969. DOI: 10.1016/j.eclinm.2023.102364.
Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.
Zager R Physiol Rep. 2022; 10(20):e15507.
PMID: 36305701 PMC: 9615572. DOI: 10.14814/phy2.15507.
Zager R, Johnson A Physiol Rep. 2020; 8(18):e14566.
PMID: 32940965 PMC: 7507518. DOI: 10.14814/phy2.14566.
Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1.
Atef Y, El-Fayoumi H, Abdel-Mottaleb Y, Mahmoud M Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(9):871-881.
PMID: 28589248 DOI: 10.1007/s00210-017-1389-9.